Imricor Medical Systems (ASX:IMR) COGS-to-Revenue : 1.89 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems COGS-to-Revenue?

Imricor Medical Systems's Cost of Goods Sold for the six months ended in Dec. 2023 was A$1.18 Mil. Its Revenue for the six months ended in Dec. 2023 was A$0.62 Mil.

Imricor Medical Systems's COGS to Revenue for the six months ended in Dec. 2023 was 1.89.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Imricor Medical Systems's Gross Margin % for the six months ended in Dec. 2023 was -89.41%.

Imricor Medical Systems COGS-to-Revenue Historical Data

The historical data trend for Imricor Medical Systems's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems COGS-to-Revenue Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

1.57

3.72

2.87

2.81

Imricor Medical Systems Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial				4.38	2.59	3.41	4.72	1.89

Imricor Medical Systems COGS-to-Revenue Calculation

Imricor Medical Systems's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.587	/	0.92
	=	2.81

Imricor Medical Systems's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.18	/	0.623
	=	1.89

Imricor Medical Systems (ASX:IMR) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Imricor Medical Systems's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.18 / 0.623
	=	-89.41 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Imricor Medical Systems COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems (ASX:IMR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines